ChiCTR2400080983 版本V1.0 版本创建时间2024/02/20 08:20:39 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400080983 

最近更新日期:

Date of Last Refreshed on:

2024-02-20 08:20:30 

注册时间:

Date of Registration:

2024-02-20 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

可穿戴式动态生命监测技术在围术期中的应用

Public title:

The application of wearable dynamic life monitoring technology in the perioperative period

注册题目简写:

English Acronym:

研究课题的正式科学名称:

可穿戴式动态生命监测技术在围术期中的应用

Scientific title:

The application of wearable dynamic life monitoring technology in the perioperative period

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

程慧娴 

研究负责人:

姚卫东 

Applicant:

Huixian Cheng 

Study leader:

Weidong Yao 

申请注册联系人电话:

Applicant telephone:

+86 136 3713 9648

研究负责人电话:

Study leader's telephone:

+86 139 5615 9282

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

huixian314@163.com

研究负责人电子邮件:

Study leader's E-mail:

yaowdmd@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国安徽省芜湖市赭山西路2#

研究负责人通讯地址:

中国安徽省芜湖市赭山西路2#

Applicant address:

2# Zheshanxi Road, Wuhu City, Anhui Province, China

Study leader's address:

2# Zheshanxi Road, Wuhu City, Anhui Province, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

皖南医学院第一附属医院(皖南医学院弋矶山医院)

Applicant's institution:

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

研究负责人所在单位:

皖南医学院第一附属医院(皖南医学院弋矶山医院)

Affiliation of the Leader:

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2023)伦审第(152)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

皖南医学院弋矶山医院科研与新技术伦理委员会

Name of the ethic committee:

Scientific Research and New Technology of Wannan Medical College Yijishan Hospital IRB

伦理委员会批准日期:

Date of approved by ethic committee:

2023-12-28 00:00:00

伦理委员会联系人:

吴佩

Contact Name of the ethic committee:

Pei Wu

伦理委员会联系地址:

中国安徽省芜湖市赭山西路2#

Contact Address of the ethic committee:

2# Zheshanxi Road, Wuhu City, Anhui Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 553 573 9209

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

皖南医学院第一附属医院(皖南医学院弋矶山医院)

Primary sponsor:

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

研究实施负责(组长)单位地址:

中国安徽省芜湖市赭山西路2#

Primary sponsor's address:

2# Zheshanxi Road, Wuhu City, Anhui Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽省

市(区县):

Country:

China

Province:

Anhui

City:

单位(医院):

皖南医学院第一附属医院(皖南医学院弋矶山医院)

具体地址:

中国安徽省芜湖市赭山西路2#

Institution
hospital:

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

Address:

2# Zheshanxi Road, Wuhu City, Anhui Province, China

经费或物资来源:

安徽省教育厅优秀创新团队项目

Source(s) of funding:

Anhui Provincial Department of Education Excellent Innovation Team Project

Target disease:

elderly patients

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

评估可穿戴式动态生命监测技术围术期的应用价值  

Objectives of Study:

Evaluate the perioperative application value of wearable dynamic life monitoring technology

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1、年龄>65岁;2、ASAⅠ~Ⅲ级;3、拟行择期外科手术;4、手术时长>2小时

Inclusion criteria

1. Age>65 years old; 2. ASA grades I to III; 3. Plan to undergo elective surgical procedures; 4. Surgical duration>2 hours

排除标准:

1)植入心律转复除颤器或起搏器; 2)对研究设备过敏;3)不能配合进行试验的受试者;4)近期参与其他临床试验的受试者

Exclusion criteria:

1)Implantation of a cardioverter defibrillator or pacemaker; 2)Hypersensitivity to the study device;3)inability to cooperate with wearing a wireless monitoring device;4)Recent participants in other clinical trials

研究实施时间:

Study execute time:

From 2024-02-26 00:00:00 To 2025-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-02-26 00:00:00 To 2025-02-28 00:00:00  

干预措施:

Interventions:

组别:

可穿戴组

样本量:

100

Group:

Wearable group

Sample size:

干预措施:

入组受试者按规定佩戴可穿戴检测仪与使用多参数监护仪,并完成相关数据收集

干预措施代码:

Intervention:

Wearable group participants are required to wear wearable detectors and use multi parameter monitors according to regulations, and complete relevant data collection

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽 

市(区县):

 

Country:

china 

Province:

Anhui 

City:

 

单位(医院):

皖南医学院第一附属医院(皖南医学院弋矶山医院)  

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

心律失常的检出率

指标类型:

主要指标

Outcome:

Detection rate of arrhythmia

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

皮肤过敏反应情况

指标类型:

次要指标

Outcome:

Skin allergies

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

异常生命体征发生频率

指标类型:

次要指标

Outcome:

Frequency of abnormal vital signs

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术中电磁干扰情况

指标类型:

次要指标

Outcome:

Intraoperative electromagnetic interference situation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age 100 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

网络平台,ResMan, http://www.medresman.org.cn

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

web-bassed public database, ResMan, http://www.medresman.org.cn

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-02-20 08:20:30